Načítá se...
Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
OBJECTIVE: To evaluate the association between metformin use and anemia risk in type 2 diabetes, and the time-course for this, in a randomized controlled trial (RCT) and real-world population data. RESEARCH DESIGN AND METHODS: Anemia was defined as a hemoglobin measure of <11 g/dL. In the RCTs A...
Uloženo v:
| Vydáno v: | Diabetes Care |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Diabetes Association
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7510037/ https://ncbi.nlm.nih.gov/pubmed/32801130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1104 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|